Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
about
Tumour-associated carbohydrate antigens in breast cancer.Antibody recognition of cancer-related gangliosides and their mimics investigated using in silico site mapping.NGcGM3 ganglioside: a privileged target for cancer vaccinesCarbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.Recent Development in Carbohydrate Based Anti-cancer Vaccines.Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients.Induction of leukocyte infiltration at metastatic site mediates the protective effect of NGcGM3-based vaccine.Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.Anti-idiotypic antibody mimicking a T-antigen-specific lectin inhibits human epithelial tumor cell proliferation.N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant.Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization.
P2860
Q34048052-CD6174BD-3BAA-4C5E-AA09-9D4A685BBEFAQ34247281-DB0BD9BE-058A-493C-85C2-2DED06AA5EA8Q34247856-768887F7-8A76-4EE3-B56E-2931F9526542Q34478719-18D81785-F999-4417-860C-CFC8E752BC99Q35854131-B197C1C0-DE20-47B4-9B7D-D0984284717DQ36598529-2584DB9C-1E3B-4C5E-B8AF-42D6F6296EA8Q36978403-E2B4C1A6-B819-4C4B-9B59-DA061E5788D7Q37280403-F75CFFDD-C9C0-4123-B31A-9370ACABA943Q37483080-99D992D4-4804-4B38-88A7-19EEFE10AFA6Q37773248-655C2332-40AA-4D29-B2FE-9D70BA4F64AAQ38344729-6F4EFEE4-7FD5-46C5-9098-3225EB61CE7BQ39350862-20D3F46C-5E4C-483E-8ED2-A63DA96782FAQ47305791-2518BEB2-9CDA-4005-B6F8-5F1C7F5F6C88Q48276171-26063B22-FBDE-448F-A371-6B94B519F842
P2860
Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@ast
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@en
type
label
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@ast
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@en
prefLabel
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@ast
Ganglioside-based vaccines and ...... immunotherapy against cancer.
@en
P2860
P356
P1476
Ganglioside-based vaccines and ...... e immunotherapy against cancer
@en
P2093
Ana M Vázquez
Luis E Fernández
P2860
P304
P356
10.1586/14760584.2.6.817
P577
2003-12-01T00:00:00Z